TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $454,000 | +4.8% | 31,697 | -0.2% | 0.17% | +5.7% |
Q4 2021 | $433,000 | -16.7% | 31,767 | 0.0% | 0.16% | -25.8% |
Q3 2021 | $520,000 | -2.8% | 31,767 | 0.0% | 0.21% | -2.7% |
Q2 2021 | $535,000 | -12.3% | 31,767 | -4.9% | 0.22% | -19.5% |
Q1 2021 | $610,000 | -9.2% | 33,408 | -9.5% | 0.27% | -15.8% |
Q4 2020 | $672,000 | +2.1% | 36,931 | +0.2% | 0.32% | -10.0% |
Q3 2020 | $658,000 | -0.5% | 36,861 | 0.0% | 0.36% | -6.3% |
Q2 2020 | $661,000 | +18.0% | 36,861 | 0.0% | 0.38% | -3.5% |
Q1 2020 | $560,000 | -23.0% | 36,861 | 0.0% | 0.40% | -0.8% |
Q4 2019 | $727,000 | +14.1% | 36,861 | -0.5% | 0.40% | +6.4% |
Q3 2019 | $637,000 | -3.2% | 37,029 | -0.4% | 0.38% | -6.0% |
Q2 2019 | $658,000 | -13.2% | 37,196 | 0.0% | 0.40% | -15.3% |
Q1 2019 | $758,000 | – | 37,196 | – | 0.47% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |